California's recalls reach the downstream buyer

§	The Regulator Brief Issue 018 · September 21, 2026 · Read on web →

Headlines this week

The Department of Cannabis Control published three more recall notices on September 14 and 15, each carrying the same finding: the cannabis was produced under unsanitary conditions, and the controls used to cultivate it did not conform with pesticide statutes and regulations. That is the language DCC used on September 10, when it recalled Natura Manufacturing's infused flower after the death of a cultivation worker and the suspension of a large licensed farm. The notice filed on September 15 by 510 Consultants LLC adds the detail that changes who should be reading this: the cannabis, it says, was sourced from a third-party cultivator. The recalling licensee was a buyer, not the grower at fault. DCC has not named a cultivator common to the notices and the investigation is open, so the chain cannot yet be traced to a single source. What is already clear is where the recall obligation lands — on whoever holds the product, not on whoever contaminated it.

This week at a glance

Top story. California's DCC published three further adulteration recalls on September 14 and 15 (licences C11-0002011-LIC and C12-0000453-LIC), all citing non-conforming pesticide controls, and one of them states the cannabis came from a third-party cultivator — putting the recall duty on a downstream purchaser while the investigation into the source remains open.

Next three.

1. Michigan fined a processor $2 million and pulled both its licences, with a surveillance camera pointed at a wall as the anchor violation.
2. Maryland put amended packaging rules into force on September 14 and opened a harsher draft for comment that closes September 30.
3. The Federal Reserve named marijuana businesses as its worked example of a higher-risk client category in proposed community-bank guidance.

Advertise with us

Limited slots · Newsletter subscribers & early users first

Your brand, in front of the people who write the compliance checks.

We are opening a set of promotional placements across both The Regulator Brief and cannabisregulations.ai — an array of options built to span every budget, from single-issue newsletter placements to site-wide visibility on the state legality database and blog. Slots are limited, and for now they are offered only to newsletter subscribers and early users.

Fill out the form to learn more → Federal & agency desk

Why it matters: Community banks hold most cannabis operating accounts, and they now have a supervisory document steering them toward premium transaction-monitoring vendors specifically for marijuana-related clients. That cost does not stay at the bank. Expect it as higher account fees, tighter onboarding diligence, or declines at the small institutions that have been the sector's most reliable banking route. The comment window is open and operators can file.

The Board of Governors of the Federal Reserve System published a proposed third-party risk management guide for traditional community banking organizations on September 15 (FR Doc. 2026-18852; 91 FR 58438; Docket No. OP-1880). In the BSA/AML section, the text says that where a bank's clients present higher risk — giving marijuana-related businesses as the example — tools with more advanced capabilities may be appropriate. The guide is non-binding. Comments are due November 16, 2026.

Why it matters: Alabama had been holding the April Schedule III order at the state line while it worked out the interaction with its own controlled-substances law. Withdrawal clears that block for Alabama-licensed medical operators. More broadly, it is a data point on how quickly the remaining objecting states fold — which is the question governing whether Schedule III becomes operationally real or stays a federal abstraction.

The Alabama State Committee of Public Health, the governing body of the Alabama Department of Public Health, voted unanimously on Thursday, September 18 to withdraw the objection it filed in May 2026, following a procedural public hearing. Under Alabama law a federal scheduling change generally takes effect at state level after 30 days unless the Committee objects. The April 2026 order placed FDA-approved marijuana products and certain state-licensed medical marijuana products into Schedule III.

Why it matters: This is the week's most concrete change for anyone who moves product or cash. Across Delaware, New Jersey, Pennsylvania and the Virgin Islands, the smell of marijuana plus a burnt joint no longer opens the door to a strip search incident to arrest. Transport drivers, delivery staff and cash couriers stopped on the road now have a precedential limit behind them, even though the officers in this case still received qualified immunity.

On September 17 the U.S. Court of Appeals for the Third Circuit held in a precedential opinion (No. 25-2860) that an arrestee not being admitted to a jail's general population has a Fourth Amendment right against strip search absent consent, exigent circumstances, or a warrant supported by probable cause that a search under the clothing will produce a weapon, contraband or evidence. Officers had smelled marijuana, seen a burnt joint, searched the plaintiff twice on scene finding nothing, then transported him to a station solely to strip search him.

Why it matters: Insurance is the constraint operators hit after banking. Carriers willing to write a dispensary are few, and those that will often price federal illegality into the premium. The bill would not compel any carrier to write the risk, so nothing changes at renewal. Its value is as a read on whether the post-Schedule III federal agenda extends past banking, and whether Financial Services moves anything cannabis-adjacent this Congress.

Reps. Nydia Velázquez (D-NY) and Warren Davidson (R-OH) introduced H.R. 10471, the Clarifying Law Around Insurance of Marijuana Act, on September 16; it was referred to the House Committee on Financial Services. It would bar federal agencies from penalising insurers, brokers, agents and employees for covering a cannabis-related legitimate business operating under state, local or tribal law, and bar insurers from terminating policies solely because of the nature of the business. A Senate companion, S. 5049, was filed in July. This is the fourth consecutive Congress in which the measure has been introduced.

Statehouse roundup

Why it matters: Two states found contaminated product two different ways in the same week. California's chain began with an enforcement trigger and is being executed through licensee notices; Missouri's came out of a state-run shelf-sampling programme that tests independently of the licensee's own certificates of analysis. For operators, the lesson is that passing your contracted lab is no longer where exposure ends, and that a recall can arrive for someone else's failure.

California's DCC published recall notices on September 14 and 15 for Peace and Joy LLC dba Tree House (C11-0002011-LIC) and 510 Consultants LLC (C12-0000453-LIC), reason code “Adulterated: Other,” business recall date September 9. On September 16 the Missouri DHSS Division of Cannabis Regulation recalled Juicy J's infused pre-rolls made by CCMRB Processing, LLC (licence MAN000103) after an Aspergillus failure, flagged through the routine sampling initiative the Division implemented in July 2025. No adverse reactions have been reported in the Missouri matter.

Why it matters: The anchor violation was a surveillance camera in an extraction room pointed at a wall — the kind of finding that reads as a minor citation on an inspection report. It ended two licences and carried a $2 million penalty. If you run extraction in Michigan, camera coverage of the process rather than the room is now a licence-level risk, and the CRA has shown it will litigate a contested case for nearly three years to get there.

On September 16 the Michigan Cannabis Regulatory Agency announced closure of Michigan Investment 10 LLC's adult-use processor licence, revocation of its medical processor licence, and a $2 million fine, in final orders ENF-23-00784 and ENF-23-00785 issued by Executive Director Brian Hanna. The orders follow a summary suspension in November 2023, a contested case hearing in January 2024, and an administrative law judge's proposal for decision on June 18, 2026 which the CRA accepted. They take effect September 24.

Why it matters: Pennsylvania has no adult-use market, and the gas-station THC channel filled the gap. The Attorney General is now treating that channel as a corrupt-organizations case rather than a regulatory one. Any hemp brand with Pennsylvania convenience or smoke-shop distribution should assume its downstream accounts sit inside an active statewide investigation, and that warehouse-to-retail logistics is where the charges attach.

On September 14 Attorney General Sunday announced charges against 12 people following a statewide investigating grand jury recommendation. The alleged ring moved marijuana and high-THC products from warehouses in Plum Borough, Pittston and Bensalem into convenience stores and smoke shops statewide. Charges include corrupt organizations, dealing in proceeds of illegal activity, and felony drug trafficking; investigators traced roughly $18.7 million in alleged proceeds and seized about 150,000 items. No case or docket numbers were released. All defendants are presumed innocent.

Why it matters: Two live obligations in one state. The adopted package already changed what goes on the box. The draft behind it is the one to read: a licensee that misses an official MCA communication by 30 days could lose a conditional licence, and renewals would be denied for tax arrears. Every other rule in the package can be met by changing a label or a training vendor. That one can be breached by an unmonitored inbox.

Amended COMAR 14.17.01, .05, .10, .12, .13, .18 and .22 took effect September 14 (adopted August 13; Notice of Final Action printed in the Maryland Register on September 4), making sublingual pouches a category, ending plain packaging and tightening youth-appeal limits. The Maryland Cannabis Administration separately posted draft amendments implementing Chapter 375 of 2026 for informal comment, closing September 30. The draft would rescind conditional licences for a 30-day failure to respond to MCA, deny renewals for tax arrears, raise the micro dispensary employee cap from 10 to 20, and replace Responsible Vendor Training with a Cannabis Agent Training programme.

Why it matters: This is the cheapest window Massachusetts licensees will get to shape rules binding them into 2027 and beyond — testing, delivery opt-outs, advertising and loyalty, seed sales at retail, transporter consolidation, agent badging and statewide licence caps are all in scope. Draft votes are in December, which means influence happens in October and November, not at the public hearing in early 2027.

The Cannabis Control Commission announced its third 2026 regulatory round on September 16 and held the first public meeting on September 17, covering medical licensing changes required after Chapter 65 of the Acts of 2026 ended the vertical-integration requirement — including a new standalone medical dispensary licence type and adult-use-to-medical transfers. A dedicated testing section of 935 CMR is in development with a public meeting slated for early October. Draft votes are calendared for December 2026, public comment and hearing for early 2027, and a final vote for March 2027.

International desk

Why it matters: This is the first Australian jurisdiction to break the presence-equals-offence rule for medicinal cannabis patients, and it will be the template every other state is pressed to copy. For operators and clinics in the Australian market it removes the largest practical deterrent to starting therapy — losing a licence for three months while unimpaired. It also gives international advocates a working model with real thresholds and safeguards attached.

The Road Transport Amendment (Medical Cannabis and Driving Offences) Bill 2026 passed both chambers of the NSW Parliament on September 18 and awaits assent. Registered drivers will no longer be automatically penalised solely because THC is detected, provided they are unimpaired and meet conditions: registration with Transport for NSW, evidence of a valid prescription, and completion of an online education programme. Roadside testing is unchanged. Below a 50 ng/ml laboratory threshold no further action follows; at or above it, a first or second detection in two years draws a warning and a third draws a $722 fine and a minimum three-month suspension. The scheme covers unrestricted licence holders only. Implementation is expected late 2026 to early 2027.

Why it matters: Britain's CBD market has run for years on a tolerated list of unauthorised novel foods, with enforcement discretion left to local authorities. If Ministers accept the recommendation, roughly 3,000 products linked to these three applications get an actual legal basis and a defined compliance specification — and five years of data protection means the authorisation belongs to the applicants, not the category. Everyone else stays in the queue.

The Food Standards Agency Board met in Swansea on September 16 and agreed that recommendations on three applications are suitable for presentation to Ministers in England and Wales, who make the final decision. The applications are RP 7 (synthetic CBD, Chanelle McCoy CBD Ltd.), RP 350 (CBD isolate, Cannaray Brands Ltd.) and RP 427 (CBD isolate, EIHA Projects GmbH), all at least 98% pure and intended for adults at a maximum 10 mg per day. Recommended conditions include labelling the provisional acceptable daily intake, warnings for under-18s and other vulnerable groups, and strict delta-9 THC specifications. The FSA received 46 consultation responses, 68% supporting the proposals.

From our database

First complete state legality database

Every cannabinoid. Every state. One database.

Recreational, medical, THCA, Delta-8, Delta-9, HHC, CBD, and more — cross-referenced across all 50 states plus DC and Puerto Rico. Updated as laws move. The only single source operators can use to scope multi-state compliance before drafting product, packaging, or shipping policy.

Open the state laws database → Need help with anything in this brief?

Ask the compliance assistant

Put a jurisdiction and a product in front of it and get the governing rule, the citation, and the effective date. Useful for scoping before you spend counsel hours.

Open the assistant →

Find cannabis and hemp counsel

Nothing in this brief is legal advice. When a recall notice, a contested case, or a comment deadline lands on you, talk to your counsel — or find one by jurisdiction and practice area.

Browse the directory → One thing to read

Texas is the largest state where the question “is CBD legal here” still produces different answers from retailers, distributors and their counsel, and the gap between what DSHS registration covers and what the 2026 rule overhaul changed is where most of the confusion sits. Our new guide walks the current position — who has to register, what a product has to test at, and which parts of the answer are still being litigated. Worth twenty minutes if you ship into Texas or stock a Texas shelf. Read the summary →